Third International Congress on Epilepsy, Brain, and Mind: Part 2

Epilepsy and Behavior

Volumn 50, Issue , 2015, Pages 138-159

  Rektor, Ivan ^a   Schachter, Steven C ^b   Arya, Ravindra ^c   Arzy, Shahar ^d,e   Braakman, Hilde ^f   Brodie, Martin J ^g   Brugger, Peter ^h   Chang, Bernard S ^b   Guekht, Alla ⁱ   Hermann, Bruce ^j   Hesdorffer, Dale C ^k   Jones Gotman, Marilyn ^l   Kanner, Andres M ^m   Garcia Larrea, Luis ⁿ   Mareš, Pavel ^o   Mula, Marco ^p   Neufeld, Miri ^q   Risse, Gail L ^r   Ryvlin, Philippe ^s,t   Seeck, Margitta ^u   Tomson, Torbjörn ^v   Korczyn, Amos D ^q   more..

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^b HARVARD MEDICAL SCHOOL   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^e HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^g WESTERN INFIRMARY   (United Kingdom)

^h UNIVERSITY HOSPITAL ZURICH   (Switzerland)

ⁱ PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^j UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^k Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^l MCGILL UNIVERSITY   (Canada)

^m UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

ⁿ HÔPITAL NEUROLOGIQUE   (France)

^o INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^p ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^q TEL AVIV UNIVERSITY   (Israel)

^r MINNESOTA EPILEPSY GROUP   (United States)

^s LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^t LYON NEUROSCIENCE RESEARCH CENTER   (France)

^u GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^v KAROLINSKA INSTITUTE   (Sweden)

more..

Author keywords

Aggression; Cognition; Depression; Epilepsy; Euphoria; Obesity; Obsessive compulsive disease; Sudden unexpected death in epilepsy

Indexed keywords

ANTICONVULSIVE AGENT; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

AGGRESSION; BEHAVIOR THERAPY; BIPOLAR DISORDER; BODY MASS; BRAIN; BRAIN FUNCTION; BRAIN STEM; COGNITION; COGNITIVE DEFECT; COMORBIDITY; COMPULSION; DIFFUSION TENSOR IMAGING; EATING DISORDER; EPILEPSY; EUPHORIA; EXERCISE; FEEDING BEHAVIOR; FRONTAL LOBE EPILEPSY; GOURMAND SYNDROME; HALLUCINATION; HUMAN; HYPOXEMIA; MYOCLONUS EPILEPSY; NERVE CELL NETWORK; NERVOUS SYSTEM INFLAMMATION; NOCICEPTION; NONHUMAN; OBESITY; OBSESSION; OBSESSIVE COMPULSIVE DISORDER; ORIENTATION; PAIN; PERIVENTRICULAR HETEROTOPIA; PERSONALITY; READING; RESPIRATORY FAILURE; REVIEW; SEIZURE; SEROTONINERGIC SYSTEM; SUDDEN DEATH; TEMPORAL LOBE EPILEPSY; VOLUMETRY; ALTERNATIVE MEDICINE; COGNITION DISORDERS; COMPULSIVE BEHAVIOR; CZECH REPUBLIC; INTERNATIONAL COOPERATION; MYOCLONIC EPILEPSY, JUVENILE; ORGANIZATION; PATHOLOGY; PATHOPHYSIOLOGY; PREVENTION AND CONTROL; PSYCHOLOGY; TRENDS;

AGGRESSION; ANTICONVULSANTS; BRAIN; COGNITION DISORDERS; COMPULSIVE BEHAVIOR; CONGRESSES AS TOPIC; CZECH REPUBLIC; DEATH, SUDDEN; EPILEPSY; HUMANS; INTERNATIONALITY; MIND-BODY RELATIONS, METAPHYSICAL; MYOCLONIC EPILEPSY, JUVENILE; PAIN;

EID: 84941188316     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2015.07.014     Document Type: Review

References (286)

1. Braakman H.M., Vaessen M.J., Hofman P.A., Debeij-van Hall M.H., Backes W.H., Vles J.S., et al. Cognitive and behavioral complications of frontal lobe epilepsy in children: a review of the literature. Epilepsia 2011, 52:849-856.
2. Braakman H.M., Ijff D.M., Vaessen M.J., Debeij-van Hall M.H., Hofman P.A., Backes W.H., et al. Cognitive and behavioural findings in children with frontal lobe epilepsy. Eur J Paediatr Neurol 2012, 16:707-715.
3. Braakman H.M., Vaessen M.J., Jansen J.F., Debeij-van Hall M.H., de Louw A., Hofman P.A., et al. Frontal lobe connectivity and cognitive impairment in pediatric frontal lobe epilepsy. Epilepsia 2013, 54:446-454.
4. Braakman H.M., Vaessen M.J., Jansen J.F., Debeij-van Hall M.H., de Louw A., Hofman P.A., et al. Pediatric frontal lobe epilepsy: white matter abnormalities and cognitive impairment. Acta Neurol Scand 2014, 129:252-262.
5. Vaessen M.J., Braakman H.M., Heerink J.S., Jansen J.F., Debeij-van Hall M.H., Hofman P.A., et al. Abnormal modular organization of functional networks in cognitively impaired children with frontal lobe epilepsy. Cereb Cortex 2013, 23:1997-2006.
6. Berg A.T. Epilepsy, cognition, and behavior: the clinical picture. Epilepsia 2011, 52(Suppl. 1):7-12.
7. Helmstaedter C., Aldenkamp A.P., Baker G.A., Mazarati A., Ryvlin P., Sankar R. Disentangling the relationship between epilepsy and its behavioral comorbidities - the need for prospective studies in new-onset epilepsies. Epilepsy Behav 2014, 31:43-47.
8. Carole G. D'elais 'evolutifs des syndromes 'epileptiques avant leur diagnostic: r'esultats descriptifs de l'enqûete CAROLE. Rev Neurol (Paris) 2000, 156:481-490.
9. Berg A.T. Risk of recurrence after a first unprovoked seizure. Epilepsia 2008, 49(Suppl. 1):13-18.
10. Fisher R.S. Epilepsy from the patient's perspective: review of results of a community-based survey. Epilepsy Behav 2000, 1:S9-S14.
11. Brooks-Kayal A. Molecular mechanisms of cognitive and behavioral comorbidities of epilepsy in children. Epilepsia 2011, 52(Suppl. 1):13-20.
12. Carreño M., Donaire A., Sánchez-Carpintero R. Cognitive disorders associated with epilepsy: diagnosis and treatment. Neurologist 2008, 14(6 Suppl. 1):S26-S34.
13. The neuropsychiatry of epilepsy 2002, 256-267. Cambridge University Press, Cambridge. M. Trimble, B. Schmitz (Eds.).
14. Helmstaedter C., Fritz N.E., Hoffmann J., Elger C.E. Impact of newly diagnosed and untreated symptomatic/cryptogenic epilepsy on cognition. Epilepsia 2005, 46:152.
15. Taylor J., Kolamunnage-Dona R., Marson A.G., Smith P.E., Aldenkamp A.P., Baker G.A. Patients with epilepsy: cognitively compromised before the start of antiepileptic drug treatment?. Epilepsia 2010, 51:48-56.
16. Rösche J., Uhlmann C., Fröscher W. Cognitive deficits and psychiatric disorders in patients with new-onset epilepsy. Fortschr Neurol Psychiatr 2010, 78:18-26.
17. Hermann B., Jones J., Sheth R., Dow C., Koehn M., Seidenberg M. Children with new-onset epilepsy: neuropsychological status and brain structure. Brain 2006, 129(Pt 10):2609-2619.
18. Seidenberg M., Pulsipher D.T., Hermann B. Cognitive progression in epilepsy. Neuropsychol Rev 2007, 17:445-454.
19. Hermann B.P., Jones J.E., Sheth R., Koehn M., Becker T., Fine J., et al. Growing up with epilepsy: a two-year investigation of cognitive development in children with new onset epilepsy. Epilepsia 2008, 49:1847-1858.
20. Baker G.A., Taylor J., Aldenkamp A.P., SANAD group Newly diagnosed epilepsy: cognitive outcome after 12months. Epilepsia 2011, 52:1084-1091.
21. Mula M., Hesdorffer D.C. Suicidal behavior and antiepileptic drugs in epilepsy: analysis of the emerging evidence. Drug Health Patient Saf 2011, 3:15-20.
22. Hecimovic H., Santos J.M., Carter J., Attarian H.P., Fessler A.J., Vahle V., et al. Depression but not seizure factors or quality of life predicts suicidality in epilepsy. Epilepsy Behav 2012, 24:426-429.
23. Kanner A.M. Mood disorder and epilepsy: a neurobiologic perspective of their relationship. Dialogues Clin Neurosci 2008, 10:39-45.
24. Velissaris S.L., Wilson S.J., Saling M.M., Newton M.R., Berkovic S.F. The psychological impact of a newly diagnosed seizure: losing and restoring perceived control. Epilepsy Behav 2007, 10:223-233.
25. Velissaris S.L., Wilson S.J., Newton M.R., Berkovic S.F., Saling M.M. Cognitive complaints after a first seizure in adulthood: influence of psychological adjustment. Epilepsia 2009, 5:1012-1021.
26. Jessberger S., Nakashima K., Clemenson G.D., Mejia E., Mathews E., Ure K., et al. Epigenetic modulation of seizure-induced neurogenesis and cognitive decline. J Neurosci 2007, 27:5967-5975.
27. Jessberger S., Clark R.E., Broadbent N.J., Clemenson G.D., Consiglio A., Lie D.C., et al. Dentate gyrus-specific knockdown of adult neurogenesis impairs spatial and object recognition memory in adult rats. Learn Mem 2009, 16:147-154.
28. Parent J.M., Yu T.W., Leibowitz R.T., Geschwind D.H., Sloviter R.S., Lowenstein D.H. Dentate granule cell neurogenesis is increased by seizures and contributes to aberrant network reorganization in the adult rat hippocampus. J Neurosci 1997, 17:3727-3738.
29. Nakagawa E., Aimi Y., Yasuhara O., Tooyama I., Shimada M., McGeer P.L., et al. Enhancement of progenitor cell division in the dentate gyrus triggered by initial limbic seizures in rat models of epilepsy. Epilepsia 2000, 41:10-18.
30. Scharfman H.E. Functional implications of seizure-induced neurogenesis. Adv Exp Med Biol 2004, 548:192-212.
31. Encinas J.M., Vaahtokari A., Enikolopov G. Fluoxetine targets early progenitor cells in the adult brain. Proc Natl Acad Sci U S A 2006, 103:8233-8238.
32. Von Bohlen Und Halbach O. Immunohistological markers for staging neurogenesis in adult hippocampus. Cell Tissue Res 2007, 329:409-420.
33. Kadar T., Cohen G., Sahar R., Alkalai D., Shapira S. Long-term study of brain lesions following soman, in comparison to DFP and metrazol poisoning. Hum Exp Toxicol 1992, 11:517-523.
34. Planas A.M., Soriano M.A., Ferrer I., Rodríguez Farré E. Regional expression of inducible heat shock protein-70 mRNA in the rat brain following administration of convulsant drugs. Brain Res Mol Brain Res 1994, 27:127-137.
35. Kasof G.M., Mandelzys A., Maika S.D., Hammer R.E., Curran T., Morgan J.I. Kainic acid-induced neuronal death is associated with DNA damage and a unique immediate-early gene response in c-fos-lacZ transgenic rats. J Neurosci 1995, 15:4238-4249.
36. Panegyres P.K. The effects of excitotoxicity on the expression of the amyloid precursor protein gene in the brain and its modulation by neuroprotective agents. J Neural Transm 1998, 105:463-478.
37. Erdoğan F., Gölgeli A., Arman F., Ersoy A.O. The effects of pentylenetetrazole-induced status epilepticus on behavior, emotional memory, and learning in rats. Epilepsy Behav 2004, 5:388-393.
38. Assaf F., Fishbein M., Gafni M., Keren O., Sarne Y. Pre- and post-conditioning treatment with an ultra-low dose of δ9-tetrahydrocannabinol (THC) protects against pentylenetetrazole (PTZ)-induced cognitive damage. Behav Brain Res 2011, 220:194-201.
39. Aniol V.A., Ivanova-Dyatlova A.Y., Keren O., Guekht A.B., Sarne Y., Gulyaeva N.V. A single pentylenetetrazole-induced clonic-tonic seizure episode is accompanied by a slowly developing cognitive decline in rats. Epilepsy Behav 2013, 26:196-202.
40. Taylor J., Baker G.A. Newly diagnosed epilepsy: cognitive outcome at 5years. Epilepsy Behav 2010, 18:397-403.
41. Hermann B.P., Jones J.E., Jackson D.C., Seidenberg M. Starting at the beginning: the neuropsychological status of children with new-onset epilepsies. Epileptic Disord 2012, 14:12-21.
42. Vezzani A., Aronica E., Mazarati A., Pittman Q.J. Epilepsy and brain inflammation. Exp Neurol 2013, 244:11-21.
43. Holzer F.J., Seeck M., Korff C.M. Autoimmunity and inflammation in status epilepticus: from concepts to therapies. Expert Rev Neurother 2014, 14:1181-1202.
44. Shimada T., Takemiya T., Sugiura H., Yamagata K. Role of inflammatory mediators in the pathogenesis of epilepsy. Mediators Inflamm 2014, 2014:901-902.
45. Fabene P.F., Navarro Mora G., Martinello M., Rossi B., Merigo F., Ottoboni L., et al. A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat Med 2008, 14:1377-1383.
46. Friedman A., Kaufer D., Heinemann U. Blood-brain barrier breakdown-inducing astrocytic transformation: novel targets for the prevention of epilepsy. Epilepsy Res 2009, 85:142-149.
47. Dube C.M., Ravizza T., Hamamura M., Zha Q., Keebaugh A., Fok K., et al. Epileptogenesis provoked by prolonged experimental febrile seizures: mechanisms and biomarkers. J Neurosci 2010, 30:7484-7494.
48. Vezzani A., French J., Bartfai T., Baram T.Z. The role of inflammation in epilepsy. Nat Rev Neurol 2011, 7:31-40.
49. Yasojima K., Schwab C., McGeer E.G., McGeer P.L. Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease. Brain Res 2000, 887:80-89.
50. Engelhart M.J., Geerlings M.I., Meijer J., Kiliaan A., Ruitenberg A., van Swieten J.C., et al. Inflammatory proteins in plasma and the risk of dementia: the Rotterdam study. Arch Neurol 2004, 61:668-672.
51. Amor S., Puentes F., Baker D., van der Valk P. Inflammation in neurodegenerative diseases. Immunology 2010, 129:154-169.
52. Arfanakis K., Fleischman D.A., Grisot G., Barth C.M., Varentsova A., Morris M.C., et al. Systemic inflammation in non-demented elderly human subjects: brain microstructure and cognition. PLoS One 2013, 8:e73107.
53. Mooijaart S.P., Sattar N., Trompet S., Lucke J., Stott D.J., Ford I., et al. Circulating interleukin-6 concentration and cognitive decline in old age: the PROSPER study. J Intern Med 2013, 274:77-85.
54. Bettcher B.M., Kramer J.H. Inflammation and clinical presentation in neurodegenerative disease: a volatile relationship. Neurocase 2013, 19:182-200.
55. Hovens I.B., Schoemaker R.G., van der Zee E.A., Absalom A.R., Heineman E., van Leeuwen B.L. Postoperative cognitive dysfunction: involvement of neuroinflammation and neuronal functioning. Brain Behav Immun 2014, 38:202-210.
56. Aldenkamp A.P. Effects of antiepileptic drugs on cognition. Epilepsia 2001, 42(Suppl. 1):46-49.
57. Mula M., Trimble M.R. Antiepileptic drug-induced cognitive adverse effects: potential mechanisms and contributing factors. CNS Drugs 2009, 23:121-137.
58. Halbsgut L.R., Fahim E., Kapoor K., Hong H., Friedman L.K. Certain secondary antiepileptic drugs can rescue hippocampal injury following a critical growth period despite poor anticonvulsant activity and cognitive deficits. Epilepsy Behav 2013, 29:466-477.
59. Mead G.E., Hsieh C.F., Lee R., Kutlubaev M.A., Claxton A., Hankey G.J., et al. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database Syst Rev 2012, 11. [CD009286].
60. Jaako K., Zharkovsky T., Zharkovsky A. Effects of repeated citalopram treatment on kainic acid-induced neurogenesis in adult mouse hippocampus. Brain Res 2009, 1288:18-28.
61. Jaako K., Aonurm-Helm A., Kalda A., Anier K., Zharkovsky T., Shastin D., et al. Repeated citalopram administration counteracts kainic acid-induced spreading of PSA-NCAM-immunoreactive cells and loss of reelin in the adult mouse hippocampus. Eur J Pharmacol 2011, 666:61-71.
62. Lanni C., Stanga S., Racchi M., Govoni S. The expanding universe of neurotrophic factors: therapeutic potential in aging and age-associated disorders. Curr Pharm Des 2010, 16:698-717.
63. Ubhi K., Rockenstein E., Vazquez-Roque R., Mante M., Inglis C., Patrick C., et al. Cerebrolysin modulates pronerve growth factor/nerve growth factor ratio and ameliorates the cholinergic deficit in a transgenic model of Alzheimer's disease. J Neurosci Res 2013, 91:167-177.
64. Pitkanen A., Lukasiuk K. Mechanisms of epileptogenesis and potential treatment targets. Lancet Neurol 2011, 10:173-186.
65. Dedeurwaerdere S., Friedman A., Fabene P.F., Mazarati A., Murashima Y.L., Vezzani A., et al. Finding a better drug for epilepsy: antiinflammatory targets. Epilepsia 2012, 5:1113-1118.
66. Kasteleijn-Nolst Trenité D.G.A., Schmitz B., Janz D., Delgado-Escueta A.V., Thomas P., Hirsch E., et al. Consensus on diagnosis and management of JME: from founder's observations to current trends. Epilepsy Behav 2013, 28:S87-S90.
67. Crespel A., Gelisse P., Reed R.C., Ferlazzo E., Jerney J., Schmitz B., et al. Management of juvenile myoclonic epilepsy. Epilepsy Behav 2013, 28:S81-S86.
68. Mantoan L., Walker M. Treatment options in juvenile myoclonic epilepsy. Curr Treat Options Neurol 2011, 13:355-370.
69. Striano P., Belcastro V. Treating myoclonic epilepsy in children: state of the art. Expert Opin Pharmacother 2013, 14:1355-1361.
70. Hitiris N., Brodie M.J. Evidence-based treatment of idiopathic generalised epilepsies with older antiepileptic drugs. Epilepsia 2005, 46(Suppl. 9):149-153.
71. Tomson T., Battino D., Bonizzoni E., Craig J., Lindhout D., Sabers A., et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011, 10:609-617.
72. Jentink J., Loane M.A., Dolk H., Barisic I., Garne E., Morris J.K., et al. Valproic acid monotherapy in pregnancy and major congenital malformations. N Engl J Med 2010, 362:2185-2193.
73. Meador K.J., Baker G.A., Browning N., Cohen M., Bromley R.L., Clayton-Smith J., et al. Foetal antiepileptic drug exposure and cognitive outcomes at age 6years (NEAD study): a prospective observational study. Lancet Neurol 2013, 12:244-252.
74. Christensen J., Gronborg T.K., Sorensen M.J., Schendel D., Parner E.T., Pederson L.H., et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 2013, 309:1696-1703.
75. Sundqvist A., Tomson T., Lundkvist B. Valproate as monotherapy for juvenile myoclonic epilepsy: dose effect study. Ther Drug Monit 1998, 20:149-157.
76. Mendiratta M.M., Aggarwal P. Clinical expression and EEG features of patients with juvenile myoclonic epilepsy (JME) from North India. Seizure 2003, 11:431-436.
77. Berkovic S.F., Knowlton R.C., Leroy R.F., Schiemann J., Falter U. Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy. Neurology 2007, 69:1751-1760. on behalf of the levetiracetam No 1057 study group.
78. Noachter S., Andermann E., Meyvisck P., Andermann F., Gough W.B., Schiemann-Delgado J., et al. Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures. Neurology 2008, 70:607-616.
79. Specchio L.M., Gambardella A., Giallonardo A.T., Michelucci R., Speccio N., Boero G., et al. Open label, long-term pragmatic study on levetiracetam in the treatment of juvenile myoclonic epilepsy. Epilepsy Res 2006, 7:32-39.
80. Stephen L.J., Kelly K., Parker P., Brodie M.J. Levetiracetam monotherapy - outcomes from an epilepsy clinic. Seizure 2011, 20:554-557.
81. Levisohn P.M., Holland K.D. Topiramate or valproate in patients with juvenile myoclonic epilepsy: a randomized open-label comparison. Epilepsy Behav 2007, 10:547-552.
82. Kothare S.V., Valencia I., Khurana D.S., Hardison H., Melvin I.J., Legido A. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy. Epileptic Disord 2004, 6:267-270.
83. Kwan P., Brodie M.J. Phenobarbital for the treatment of epilepsy in the 21st century: a critical review. Epilepsia 2004, 45:1141-1149.
84. Biraben A., Allain H., Scarabin J.M., Schuck S., Edan G. Exacerbation of juvenile myoclonic epilepsy with lamotrigine. Neurology 2000, 55:1758.
85. Carrazana E.J., Wheeler S.D. Exacerbation of juvenile myoclonic epilepsy with lamotrigine. Neurology 2001, 56:1424-1425.
86. Crespel A., Genton P., Berramdane M.P., Coubes P., Monicard C., Baldy-Moulinier M., et al. Lamotrigine associated with exacerbations of de novo myoclonus in idiopathic generalized epilepsies. Neurology 2005, 65:672-674.
87. Machado R.A., Garcia V.F., Astencio D.G., Cuartas V.B. Efficacy and tolerability of lamotrigine in juvenile myoclonic epilepsy in adults: a prospective, unblinded, randomized controlled trial. Seizure 2013, 22:846-855.
88. Mohanraj R., Brodie M.J. Outcomes of newly diagnosed idiopathic generalised epilepsy syndromes in a non-paediatric setting. Acta Neurol Scand 2007, 115:204-208.
89. Guaranha M.S.B., De Araújo Filho G.M., Lin K., Fuilhoto L.M.F.F., Caboclo L.O.S.F., Yacubian E.M.T. Prognosis of juvenile myoclonic epilepsy is related to endophenotypes. Seizure 2011, 20:42-48.
90. Nicolson A., Marson A.G. When the first antiepileptic drug fails in a patient with juvenile myoclonic epilepsy. Pract Neurol 2010, 10:208-215.
91. Stephen L.J., Forsyth M., Kelly K., Brodie M.J. Antiepileptic drug combinations - have newer agents altered clinical outcomes?. Epilepsy Res 2012, 98:194-198.
92. Obeid T., Panayiotopoulos C.P. Clonazepam in juvenile myoclonic epilepsy. Epilepsia 1989, 30:603-606.
93. Resor S.R., Resor L.D. Chronic acetazolamide monotherapy in the treatment of juvenile myoclonic epilepsy. Neurology 1990, 40:1677-1681.
94. Camfield C.S., Camfield P.R. Juvenile myoclonic epilepsy 25years after seizure onset: a population-based study. Neurology 2009, 73:1041-1045.
95. Geithner J., Schneider F., Wang Z., Berneiser J., Herzer R., Kessler C., et al. Predictors for long-term seizure outcomes in juvenile myoclonic epilepsy: 25-63years of follow-up. Epilepsia 2012, 53:1379-1386.
96. Baykan B., Matinez-Juarez I.E., Atlindag E.A., Camfield C.S., Camfield P.R. Lifetime prognosis of juvenile myoclonic epilepsy. Epilepsy Behav 2013, 28:S18-S24.
97. Nashef L., So E.L., Ryvlin P., Tomson T. Unifying the definitions of sudden unexpected death in epilepsy. Epilepsia 2012, 53:227-233.
98. Ficker D.M., So E.L., Annegers J.F., O'Brien P.C., Cascino G.D., Belau P.G. Population-based study of the incidence of sudden unexplained death in epilepsy. Neurology 1998, 51:1270-1274.
99. Holst A., Winkel B., Risgaard B., Nielsen J.B., Rasmussen P.V., Haunsø, et al. Epilepsy and risk of sudden unexpected death in the young: a nationwide study. Epilepsia 2013, 54:1613-1620.
100. Sillanpää M., Shinnar S. Long-term mortality in childhood-onset epilepsy. N Engl J Med 2010, 363:2522-2529.
101. Tomson T., Nashef L., Ryvlin P. Sudden unexpected death in epilepsy: current knowledge and future directions. Lancet Neurol 2008, 7(11):1021-1031.
102. Nilsson L., Farahmand B.Y., Persson P.G., Thiblin I., Tomson T. Risk factors for sudden unexpected death in epilepsy: a case-control study. Lancet 1999, 353:888-893.
103. Walczak T.S., Leppik I.E., D'Amelio M., Rarick J., So E., Ahman P., et al. Incidence and risks factors in sudden unexpected death in epilepsy: a prospective cohort study. Neurology 2001, 56:519-525.
104. Langan Y., Nashef L., Sander J.W. Case-control study of SUDEP. Neurology 2005, 64:1131-1133.
105. Hitiris N., Suratman S., Kelly K., Stephen L.J., Sills G.J., Brodie M.J. Sudden unexpected death in epilepsy: a search for risk factors. Epilepsy Behav 2007, 10:138-141.
106. Hesdorffer D.C., Tomson T., Benn E., Sander J.W., Nilsson L., Langan Y., et al. Combined analysis of risk factors for SUDEP. Epilepsia 2011, 52:1150-1159.
107. Hesdorffer D.C., Tomson T., Benn E., Sander J.W., Nilsson L., Langan Y., et al. ILAE Commission on Epidemiology (Subcommission on Mortality). Do antiepileptic drugs or generalized tonic-clonic seizure frequency increase SUDEP risk? A combined analysis. Epilepsia 2012, 53:249-252.
108. Surges R., Adjei P., Kallis C., Erhuero J., Scott C.A., Bell G.S., et al. Pathologic cardiac repolarization in pharmacoresistant epilepsy and its potential role in sudden unexpected death in epilepsy: a case-control study. Epilepsia 2010, 51:233-242.
109. Aurlien D., Larsen J.P., Gjerstad L., Taubøll E. Increased risk of sudden unexpected death in epilepsy in females using lamotrigine: a nested, case-control study. Epilepsia 2012, 53:258-266.
110. Lamberts R.J., Thijs R.D., Laffan A., Langan Y., Sander J.W. Sudden unexpected death in epilepsy: people with nocturnal seizures may be at highest risk. Epilepsia 2012, 53:253-257.
111. Ryvlin P., Cucherat M., Rheims S. Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials. Lancet Neurol 2011, 10:961-968.
112. Dasheiff R.M. Sudden unexpected death in epilepsy: a series from an epilepsy surgery program and speculation on the relationship to sudden cardiac death. J Clin Neurophysiol 1991, 8:216-222.
113. Ryvlin P., Nashef L., Lhatoo S.D., Bateman L.M., Bird J., Bleasel A., et al. Incidence and mechanisms of cardiorespiratory arrests in epilepsy monitoring units (MORTEMUS): a retrospective study. Lancet Neurol 2013, 12:966-977.
114. Richter D.W., Manzke T., Wilken B., Ponimaskin E. Serotonin receptors: guardians of stable breathing. Trends Mol Med 2003, 9:542-548.
115. Faingold C.L., Randall M., Mhaskar Y., Uteshev V.V. Differences in serotonin receptor expression in the brainstem may explain the differential ability of a serotonin agonist to block seizure-induced sudden death in DBA/2 vs. DBA/1 mice. Brain Res 2011, 1418:104-110.
116. Faingold C.L., Tupal S., Randall M. Prevention of seizure-induced sudden death in a chronic SUDEP model by semichronic administration of a selective serotonin reuptake inhibitor. Epilepsy Behav 2011, 22:186-190.
117. Bateman L.M., Spitz M., Seyal M. Ictal hypoventilation contributes to cardiac arrhythmia and SUDEP: report on two deaths in video-EEG-monitored patients. Epilepsia 2010, 51:916-920.
118. Richerson G.B. Serotonergic neurons as carbon dioxide sensors that maintain pH homeostasis. Nat Rev Neurosci 2004, 5. [449-46.S].
119. Ling L., Fuller D.D., Bach K.B., Kinkead R., Olson E.B., Mitchell G.S. Chronic intermittent hypoxia elicits serotonin-dependent plasticity in the central neural control of breathing. J Neurosci 2001, 21:5381-5388.
120. Mahamed S., Mitchell G.S. Simulated apnoeas induce serotonin-dependent respiratory long-term facilitation in rats. J Physiol 2008, 586:2171-2181.
121. Buchanan G.F., Richerson G.B. Central serotonin neurons are required for arousal to CO2. Proc Natl Acad Sci U S A 2010, 107:16354-16359.
122. Hodges M.R., Wehner M., Aungst J., Smith J.C., Richerson G.B. Transgenic mice lacking serotonin neurons have severe apnea and high mortality during development. J Neurosci 2009, 29:10341-10349.
123. Hodges M.R., Tattersall G.J., Harris M.B., McEvoy S.D., Richerson D.N., Deneris E.S., et al. Defects in breathing and thermoregulation after genetic deletion of central serotonin neurons. J Neurosci 2008, 28:2495-2505.
124. Kinney H.C., Thach B.T. The sudden infant death syndrome. N Engl J Med 2009, 361:795-805.
125. Paterson D.S., Trachtenberg F.L., Thompson E.G., Belliveau R.A., Beggs A.H., Darnall R., et al. Multiple serotonergic brainstem abnormalities in sudden infant death syndrome. JAMA 2006, 296:2124-2132.
126. Duncan J.R., Paterson D.S., Hoffman J.M., Mokler D.J., Borenstein N.S., Belliveau R.A., et al. Brainstem serotonergic deficiency in sudden infant death syndrome. JAMA 2010, 303:430-437.
127. Uteshev V.V., Tupal S., Mhaskar Y., Faingold C.L. Abnormal serotonin receptor expression in DBA/2 mice associated with susceptibility to sudden death due to respiratory arrest. Epilepsy Res 2010, 88:183-188.
128. Tecott L.H., Sun L.M., Akana S.F., Strack A.M., Lowenstein D.H., Dallman M.F., et al. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature 1995, 374:542-546.
129. Brennan T.J., Seeley W.W., Kilgard M., Schreiner C.E., Tecott L.H. Sound-induced seizures in serotonin 5-HT2c receptor mutant mice. Nat Genet 1997, 16:387-390.
130. Venit E.L., Shepard B.D., Seyfried T.N. Oxygenation prevents sudden death in seizure prone mice. Epilepsia 2004, 45:993-996.
131. Tupal S., Faingold C.L. Evidence supporting a role of serotonin in modulation of sudden death induced by seizures in DBA/2 mice. Epilepsia 2006, 47:21-26.
132. Ryvlin P., Nashef L., Tomson T. Prevention of sudden unexpected death in epilepsy: a realistic goal?. Epilepsia 2013, 54(Suppl. 2):23-28.
133. Favale E., Rubino V., Mainardi P., Lunardi G., Albano C. Anticonvulsant effect of fluoxetine in humans. Neurology 1995, 45:1926-1927.
134. Kanner A.M., Kozak A.M., Frey M. The use of sertraline in patients with epilepsy: is it safe?. Epilepsy Behav 2000, 1:100-105.
135. Specchio L.M., Iudice A., Specchio N.L., Neve A., Spinelli A., Galli R., et al. Citalopram as treatment of depression in patients with epilepsy. Clin Neuropharmacol 2004, 27:133-136.
136. Thomé-Souza M.S., Kuczynski E., Valente K.D. Sertraline and fluoxetine: safe treatments for children and adolescents with epilepsy and depression. Epilepsy Behav 2007, 10:417-425.
137. Kubová H., Mareš P. Are morphologic and functional consequences of status epilepticus in infant rats progressive?. Neuroscience 2013, 235:232-249.
138. Treiman D.M. Epilepsy and violence: medical and legal issues. Epilepsia 1986, 27(Suppl. 2):S77-S104.
139. Tebartz van Elst L., Woermann F.G., Lemieux L., Thompson P.J., Trimble M.R. Affective aggression in patients with temporal epilepsy, a quantitative MRI study of the amygdala. Brain 2000, 123:234-243.
140. Gunn J.C. The prevalence of epilepsy among prisoners. Proc R Soc Med 1969, 62:60-63.
141. Gunn J., Fenton G. Epilepsy in prisons, a diagnostic survey. Br Med J 1969, 4:326-328.
142. Whitman S., Coleman T.E., Patmon C., Desai B.T., Cohen R., King L.N. Epilepsy in prison: elevated prevalence and no relationship to violence. Neurology 1984, 34:775-782.
143. Fazel S., Lichtenstein P., Grann M., Långström N. Risk of violent crime in individuals with epilepsy and traumatic brain injury: a 35-year Swedish population study. PLoS Med 2011, 8:e1001150.
144. Marsh L., Krauss G.L. Aggression and violence in patients with epilepsy. Epilepsy Behav 2000, 1:160-168.
145. Kanemoto K., Tadokoro Y., Oshima T. Violence and postictal psychosis: a comparison of postictal psychosis, interictal psychosis and postictal confusion. Epilepsy Behav 2010, 16:162-166.
146. Delgado-Esueta A.V., Mattson R.H., King L., Goldensohn E.S., Spiegel H., Madsen J., et al. The nature of aggression during epileptic seizures. N Engl J Med 1981, 305:711-716.
147. Sumer M.M., Atik L., Unal A., Emre U., Atasoy H.T. Frontal lobe epilepsy presented as ictal aggression. Case report. Neurol Sci 2007, 28:48-51.
148. Shih J.J., Falcao G., Gerpen J.V. Directed aggressive behavior in frontal lobe epilepsy: a video-EEG and ictal SPECT case study. Neurology 2009, 24:1804-1806.
149. Tassinari C.A., Tassi L., Calandra-Buonaura G., Stanzani-Maserati M., Fini N., Sartori I., et al. Biting behavior, aggression and seizures. Epilepsia 2005, 46:654-663.
150. Pandya N.S., Vrbancic M., Ladino L.D., Tellez-Zenteno J. Epilepsy and homicide. Neuropsychiatr Dis Treat 2013, 9:667-673.
151. Schachter S.C. Aggression in epilepsy. Psychiatric issues in epilepsy: a practical guide to diagnosis and treatment 2007, 306-320. Wolters Kluwer/Lippincott Williams & Wilkins, Baltimore, MD. 2nd ed. A.B. Ettinger, A.M. Kanner (Eds.).
152. Lin J.L., Mula M., Hermann B.P. Uncovering the neurobehavioural comorbidities of epilepsy over a life span. Lancet 2012, 380:1180-1192.
153. Comai S., Tau M., Gobbi G. The psychopharmacology of aggressive behaviour: a translational approach. Part I: neurobiology. J Clin Psychopharmacol 2012, 32:83-94.
154. Brodie M.J., Covanis A., Lerche H., Perucca E., Sills G.J., White S. Antiepileptic drug therapy: does mechanisms of action matter?. Epilepsy Behav 2011, 21:331-341.
155. Comai S., Tau M., Pavlovic Z., Gobbi G. The psychopharmacology of aggressive behaviour: a translational approach. Part 2: clinical studies using atypical antipsychotics, anticonvulsants and lithium. J Clin Psychopharmacol 2012, 32:237-260.
156. Huband N., Ferriter M., Nathan R., Jones M. Antiepileptics for aggression and associated impulsivity. Cochrane Database Syst Rev 2010, 17. [CDOO 3499].
157. Lynch B.A., Lambeng N., Nolka K., Kensel-Hammes P., Bajjalieh S.H., Matagne A., et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci U S A 2004, 101:9861-9866.
158. Cramer J.E., De Rue K., Devinsky O., Edrich P., Trimble M.R. A systematic review of the behavioral effect of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials. Epilepsy Behav 2003, 4:124-132.
159. Levisohn P.M., Mintz M., Hunter S.J., Yang H., Jones J. Neurocognitive effects of adjunctive levetiracetam in children with partial onset seizures: a randomized, double-blind, placebo-controlled non-inferiority trial. Epilepsia 2009, 50:2377-2389. on behalf of the NO1103 Levetiracetam study group.
160. Schiemann-Delgado J., Yang H., De La Logue C., Stalvey T.J., Jones J., Legoff D., et al. A long-term open-label extension study assessing cognition and behavior, tolerability, safety and efficacy of adjunctive levetiracetam in children aged 4 to 16years with partial onset seizures. J Child Neurol 2012, 27:80-89.
161. Labiner D., Ettinger A.B., Fakhoury T.A., Chung S.S., Shnecker B., Tatum W.O., et al. Effect of lamotrigine compared with levetiracetam in anger, hostility and total mood in patients with partial epilepsy. Epilepsia 2009, 50:434-442.
162. Mula M., Trimble M.A., Sander J.W.A.S. Psychiatric adverse events in patients with epilepsy and learning disabilities taking levetiracetam. Seizure 2004, 13:55-57.
163. Mula M., Trimble M.R., Yuen A., Liu R.S.N., Sander J.W.A.S. Psychiatric adverse events during levetiracetam therapy. Neurology 2003, 61:704-708.
164. Dinkelacker V., Dietl T., Widman G., Lengler U., Elger C.E. Aggressive behaviour of epilepsy patients in the course of levetiracetam add-on therapy: report of 22 mild to severe cases. Epilepsy Behav 2003, 4:537-547.
165. Mohanraj R., Parker P.G., Stephen L.J., Brodie M.J. Levetiracetam in refractory epilepsy: a prospective observational study. Seizure 2005, 14:23-27.
166. White J.R., Walczak T.S., Leppik I.E., Rarick J., Tran T., Beniak T.E., et al. Discontinuation of levetiracetam because of behavioral side effects. Neurology 2003, 61:1218-1221.
167. Helmstaedter C., Mihov Y., Toliat M.R., Thiele H., Nuernberg P., Schoch S., et al. Genetic variation in dopaminergic activity is associated with the risk for psychiatric side effects of levetiracetam. Epilepsia 2013, 54:36-44.
168. Major M., Greenberg E., Khan A., Thiele E.A. Pyridoxine supplementation for the treatment of levetiracetam-induced behavior side effects in children: preliminary results. Epilepsy Behav 2008, 13:527-539.
169. Davis G.P., McCarthy J.T., Magill D.B., Coffey B. Behavioral effects of levetiracetam mitigated by pyridoxine. J Child Adolesc Psychopharmacol 2009, 19:209-211.
170. Mula M., Trimble M.R., Lhatoo S.D., Sander J.W.A.S. Topiramate and psychiatric adverse events in patients with epilepsy. Epilepsia 2003, 44:659-663.
171. Stephen L.J., Kelly K., Wilson E.A., Parker P., Brodie M.J. Prospective audit of adjunctive zonisamide in an everyday clinical setting. Epilepsy Behav 2010, 17:455-460.
172. Steinhoff B.J., Ben-Menachem E., Ryvlin P., Shorvon S., Kramer L., Satlin A., et al. Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures. Epilepsia 2013, 54:1481-1489.
173. Rosenfeld W., Rozentals G., Yang H., Squillacote D., Fain R., Kumar D., et al. Poster presented at the 41st Annual Meeting of the Child Neurology Society. Huntington Beach, California, US, October 31st to November 3rd, 2012 2012.
174. Ettinger A.B., LoPresti A., Yang H., Williams B., Zhou S., Fain R., et al. Review of psychiatric and behavioral events in perampanel clinical studies. Poster presented at the American Epilepsy Society, Washington DC, USA. December 6-10th, 2013 2013.
175. Weishmann U.C., Baker G.A. Self-reported feelings of anger and aggression towards others in patients on levetiracetam: data from the UK antiepileptic drug register. BMJ Open 2013, 3:e002564. 10.1136/bmjopen-2013-002564.
176. Lem S. Summa technologiae 1964/2013, University of Minnesota Press, Minneapolis.
177. Berlucchi G., Aglioti S.M. The body in the brain revisited. Exp Brain Res 2010, 200:25-35.
178. Brugger P., Kollias S.S., Müri R.M., Crelier G., Hepp-Reymond M.-C., Regard M. Beyond re-membering: phantom sensations of congenitally absent limbs. Proc Natl Acad Sci U S A 2000, 97:6167-6172.
179. Curt A., Yengue C.N., Hilti L.M., Brugger P. Supernumerary phantom limbs in spinal cord injury. Spinal Cord 2011, 49:588-595.
180. Antoniello D., Kluger B.M., Sahlein D.H., Heilman K.M. Phantom limb after stroke: an underreported phenomenon. Cortex 2010, 46:1114-1122.
181. Russel W.R., Whitty C.W.M. Studies in traumatic epilepsy. Part 2: focal motor and somatic sensory fits: a study of 85 cases. J Neurol Neurosurg Psychiatry 1955, 16:73-97.
182. Millonig A., Bodner T., Donnemiller E., Wolf E., Unterberger I. Supernumerary phantom limb as a rare symptom of epileptic seizures - case report and literature review. Epilepsia 2011, 52:e97-e100.
183. Schott G.D. Revealing the invisible: the paradox of picturing a phantom limb. Brain 2014, 137:960-969.
184. Brugger P., Regard M., Landis T. Illusory reduplication of one's own body: phenomenology and classification of autoscopic phenomena. Cogn Neuropsychiatry 1997, 2:19-38.
185. Ardila A., Gomez J. Paroxysmal "feeling of somebody being nearby". Epilepsia 1988, 29:188-189.
186. Brugger P., Regard M., Landis T. Unilaterally felt "presences": the neuropsychiatry of one's invisible doppelgänger. Neuropsychiatry Neuropsychol Behav Neurol 1996, 9:114-122.
187. Critchley M. The idea of a presence. Acta Psychiatr Neurol Scand 1955, 30:155-168.
188. Rektor I., Schachter S.C., Arzy S., Baloyannis S.J., Bazil C., Brázdil M., et al. Epilepsy, behavior, and art (Epilepsy, Brain, and Mind, part 1). Epilepsy Behav 2013, 28:261-282.
189. Arzy S., Seeck M., Ortigue S., Spinelli L., Blanke O. Induction of an illusory shadow person. Nature 2006, 443:287.
190. Heydrich L., Blanke O. Distinct illusory own-body perceptions caused by damage to posterior insula and extrastriate cortex. Brain 2013, 136:790-803.
191. Genner T. Das Sehen des eigenen Spiegelbildes als epileptisches Aequivalent. Wien Klin Wochenschr 1947, 59:656-658.
192. Maximov K. Epilepsie occipital avec hallucinations héautoscopiques. Acta Neurol Belg 1973, 73:320-323.
193. Dieguez S. Doubles everywhere: literary contributions to the study of the bodily self. Brain disease and doctors in novels, theater, and film 2013, 77-115. Karger, Basel. J. Bogousslavsky, S. Dieguez (Eds.).
194. Brugger P., Agosti R., Regard M., Wieser H.-G., Landis T. Heautoscopy, epilepsy and suicide. J Neurol Neurosurg Psychiatry 1994, 57:838-839.
195. Brugger P., Blanke O., Regard M., Bradford D.T., Landis T. Polyopic heautoscopy: case report and review of the literature. Cortex 2006, 42:666-674.
196. Anzellotti F., Onofrj V., Maruotti V., Ricciardi L., Franciotti R., Bonanni L., et al. Autoscopic phenomena: case report and review of literature. Behav Brain Funct 2011, 7:1-11.
197. Hoepner R., Labudda K., Hoppe M., Schoendienst M., Schulz R., Tomka-Hoffmeister M., et al. Unilateral autoscopic phenomena as a lateralizing sign in focal epilepsy. Epilepsy Behav 2012, 23:360-363.
198. Maillard L., Vignal J.P., Anxionnat R., Taillandier L., Vespignani H. Semiologic value of ictal autoscopy. Epilepsia 2004, 45:391-394.
199. Magri R., Mocchetti E. L' asomatoscopia (autoscopia negativa) in una epilettica. Arch Psicol Neurol Psichiatr 1967, 28:572-585.
200. Nishibayashi H., Nakai Y., Tamura M., Ogura M., Uematsu Y., Itakura T. Ictal asomatognosia due to dominant superior parietal cortical dysplasia. J Clin Neurosci 2011, 18:141-142.
201. Dorpat T.L. Phantom sensations of internal organs. Compr Psychiatry 1971, 12:27-35.
202. Sollier P. Autoscopie interne vérifiée expérimentalement. J Psychol Norm Pathol 1908, 5:354-358.
203. Skolnick A.A. Natasha Demkina: the girl with normal eyes. Skept Inq 2005, 29:34-37.
204. Green C. Out-of-the-body experiences 1968, Institute of Psychophysical Research, Oxford.
205. Vuilleumier P., Depland P.A., Assal G., Regli F. Out-of-body and astral journeys. Heautoscopy, ecstasia and experimental hallucinations of epileptic origin. Rev Neurol 1997, 153:115-119.
206. Devinsky O., Feldmann E., Burrowes K., Bromfield E. Autoscopic phenomena with seizures. Arch Neurol 1989, 46:1080-1088.
207. Brugger P., Mohr C. Out of the body, but not out of mind. Cortex 2009, 45:137-140.
208. Blanke O., Metzinger T. Full-body illusions and minimal phenomenal selfhood. Trends Cogn Sci 2009, 13:7-13.
209. Blanke O., Ortigue S., Landis T., Seeck M. Stimulating illusory own-body perceptions. Nature 2002, 419:269-270.
210. Blanke O., Mohr C., Michel C.M., Pacual-Leone A., Brugger P., Seeck M., et al. Linking out-of-body experiences and self processing to mental own-body imagery at the temporoparietal junction. J Neurosci 2005, 19:550-557.
211. Lopez C., Heydrich L., Seeck M., Blanke O. Abnormal self-location and vestibular vertigo in a patient with right frontal lobe epilepsy. Epilepsy Behav 2010, 17:289-292.
212. Penfield W.W., Erickson T.C. Epilepsy and cerebral localization 1941, Charles C. Thomas, Oxford.
213. Jaffe S.L. Letter to the editor. Neurology 2000, 55:603.
214. Brugger P. Hostile interactions between body and self. Dialogues Clin Neurosci 2007, 9:210-213.
215. Brugger P. From phantom limb to phantom body. Varieties of extracorporeal awareness. Human body perception from the inside out 2006, 171-209. Oxford University Press, Oxford. G. Knoblich, I.M. Thornton, M. Grosjean, M. Shiffrar (Eds.).
216. Peer M., Lyon R., Arzy S. Orientation and disorientation: Lessons from patients with epilepsy. Epilepsy Behav 2014, 41:149-157.
217. Berrios G.E. Orientation failures in medicine and psychiatry: discussion paper. J R Soc Med 1983, 76:379-385.
218. Hartley T., Lever C., Burgess N., O'Keefe J. Space in the brain: how the hippocampal formation supports spatial cognition. Philos Trans R Soc Lond B Biol Sci 2014, 369:20120510.
219. MacDonald C.J., Lepage K.Q., Eden U.T., Eichenbaum H. Hippocampal "time cells" bridge the gap in memory for discontiguous events. Neuron 2011, 71:737-749.
220. Coras R., Pauli E., Li J., Schwarz M., Rössler K., Buchfelder M., et al. Differential influence of hippocampal subfields to memory formation: insights from patients with temporal pole epilepsy. Brain 2014, 137(Pt 7):1945-1957.
221. Buzsáki G., Moser E.I. Memory, navigation and theta rhythm in the hippocampal-entorhinal system. Nat Neurosci 2013, 16:130-138.
222. Göbel S., Walsh V., Rushworth M.F. The mental number line and the human angular gyrus. Neuroimage 2001, 14:1278-1289.
223. Oliveri M., Koch G., Caltagirone C. Spatial-temporal interactions in the human brain. Exp Brain Res 2009, 195:489-497.
224. Arzy S., Adi-Japha E., Blanke O. The mental time line: an analogue of the mental number line in the mapping of life events. Conscious Cogn 2009, 18:781-785.
225. Gusnard D.A., Akbudak E., Shulman G.L., Raichle M.E. Medial prefrontal cortex and self-referential mental activity: relation to a default mode of brain function. Proc Natl Acad Sci U S A 2001, 98:4259-4264.
226. Fox M.D., Snyder A.Z., Vincent J.L., Corbetta M., Van Essen D.C., Raichle M.E. The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proc Natl Acad Sci U S A 2005, 102:9673-9678.
227. Golland Y., Bentin S., Gelbard H., Benjamini Y., Heller R., Nir Y., et al. Extrinsic and intrinsic systems in the posterior cortex of the human brain revealed during natural sensory stimulation. Cereb Cortex 2007, 17:766-777.
228. Arzy S., Arzouan Y., Adi-Japha E., Solomon S., Blanke O. The "intrinsic" system in the human cortex and self-projection: a data driven analysis. Neuroreport 2010, 21:569-574.
229. Blanke O., Landis T., Spinelli L., Seeck M. Out-of-body experience and autoscopy of neurological origin 2004, vol. 127. Oxford Univ Press, Oxford.
230. Arzy S., Landis T., Blanke O. Out-of-body, out-of-time: abnormal unity of body and self in space and time. Endophysics, time, quantum and the subjective 2005, 507-530. World Scientific Publishing Co, Singapore. R. Buccheri, A.C. Elitzur, M. Saniga (Eds.).
231. Staton R.D., Brumback R.A., Wilson H. Reduplicative paramnesia: a disconnection syndrome of memory. Cortex 1982, 18:23-35.
232. Aziz V.M., Warner N.J. Capgras' syndrome of time. Psychopathology 2005, 38:49-52.
233. Arzy S., Molnar-Szakacs I., Blanke O. Self in time: imagined self-location influences neural activity related to mental time travel. J Neurosci 2008, 28:6502-6507.
234. Arzy S., Thut G., Mohr C., Michel C.M., Blanke O. Neural basis of embodiment: distinct contributions of temporoparietal junction and extrastriate body area. J Neurosci 2006, 26:8074-8081.
235. Regard M., Landis T. "Gourmand syndrome": eating passion associated with right anterior lesions. Neurology 1997, 48:1185-1190.
236. Uher R., Treasure J. Brain lesions and eating disorders. J Neurol Neurosurg Psychiatry 2005, 76:852-857.
237. Kurian M., Schmitt-Mechelke T., Korff C., Delavelle J., Landis T., Seeck M. "Gourmand syndrome""in a child with pharmacoresistant epilepsy. Epilepsy Behav 2008, 13:413-415.
238. Daniels Z.S., Nick T.G., Liu C., Cassedy A., Glauser T.A. Obesity is a common comorbidity for pediatric patients with untreated, newly diagnosed epilepsy. Neurology 2009, 73:658-664.
239. Glauser T.A., Cnaan A., Shinnar S., Hirtz D.G., Dlugos D., Masur D., et al. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. N Engl J Med 2010, 362:790-799.
240. Flegal K.M., Carroll M.D., Ogden C.L., Curtin L.R. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010, 303:235-241.
241. Statistics Canada http://www.statcan.gc.ca/pub/82-625-x/2011001/article/11411-eng.htm.
242. Eurostat http://epp.eurostat.ed.europa.eu/statistics_explained/index.php/overweight_and_obesity_-_BMI_statistics.
243. Janousek J., Barber A., Goldman L., Klein P. Obesity in adults with epilepsy. Epilepsy Behav 2013, 28:391-394.
244. Small D.M., Jones-Gotman M., Zatorre R.J., Petrides M., Evans A.C. A role for the right anterior temporal lobe in taste quality recognition. J Neurosci 1997, 17(13):5136-5142.
245. Karlsson J., Persson L.O., Sjostrom L., Sullivan M. Psychometric properties and factor structure of the Three-Factor Eating Questionnaire (TFEQ) in obese men and women. Results from the Swedish Obese Subjects (SOS) study 2000, 10.1038/sj.ijo.0801442,24(12).
246. Craig C.L., Marshall A.L., Sjostrom M., Bauman A.E., Booth M.L., Ainsworth B.E., et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003, 35:1381-1395.
247. Doty R.L., Shaman P., Dann M. Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav 1984, 32:489-502.
248. Jones-Gotman M., Zatorre R.J. Odor identification in humans before and after resection from a temporal lobe. Soc Neurosci Abstr 1995, 21:2085.
249. Insel T.R. Toward a neuroanatomy of obsessive-compulsive disorder. Arch Gen Psychiatry 1992, 49:739-744.
250. McKay D., Abramowitz J.S., Calamari J.E., Kyrios M., Radomsky A., Sookman D., et al. A critical evaluation of obsessive-compulsive disorder subtypes: symptoms versus mechanisms. Clin Psychol Rev 2004, 24:283-313.
251. Berthier M.L., Kulisevsky J., Gironell A., Heras J.A. Obsessive compulsive disorder associated with brain lesions: clinical phenomenology, cognitive function and anatomic correlates. Neurology 1996, 47:353-361.
252. Jenike M.A. Theories of etiology. Practical management 1998, 203-221. Mosby Inc., St. Louis. 3rd ed. M.A. Jenike, L. Baer, W.E. Minichiello (Eds.).
253. Robertson M.M. Tourette syndrome, associated conditions and the complexities of treatment. Brain 2000, 123:425-462.
254. Isaacs K.L., Philbeck J.W., Barr W.B., Devinsky O., Alper K. Obsessive-compulsive symptoms in patients with temporal lobe epilepsy. Epilepsy Behav 2004, 5:569-574.
255. Monaco F., Cavanna A., Magli E., Barbagli D., Collimedaglia L., Cantello R., et al. Obsessionality, obsessive-compulsive disorder, and temporal lobe epilepsy. Epilepsy Behav 2005, 7:491-496.
256. Mula M., Cavanna A.E., Critchley H., Robertson M.M., Monaco F. Phenomenology of obsessive compulsive disorder in patients with temporal lobe epilepsy or Tourette syndrome. J Neuropsychiatry Clin Neurosci 2008, 20:223-226.
257. Blumer D. Evidence supporting the temporal lobe epilepsy personality syndrome. Neurology 1999, 53(5 Suppl. 2):S9-S12.
258. Kreaepelin E. Psychiatrie. Ein Lehrbuch für Studirende und Aerzte. Sechste, vollständig umgearbeitete Auflage. II. Band. Klinische Psychiatrie 1899, 456-457. J. A. Barth, Leipzig.
259. Gibbs F.A. Ictal and non-ictal psychiatric disorders in temporal lobe epilepsy. J Nerv Ment Dis 1951, 113:522-528.
260. Guerrant J., Anderson W.W., Fischer A., Weinstein M.R., Jaros R.M., Deskins A. Personality in epilepsy 1962, Charles C Thomas, Springfield, IL.
261. Waxman S.G., Geschwind N. Hypergraphia in temporal lobe epilepsy. Neurology 1974, 24:629-636.
262. Waxman S.G., Geschwind N. The interictal behavior syndrome of temporal lobe epilepsy. Arch Gen Psychiatry 1975, 32:1580-1586.
263. Bear D.M. Temporal lobe epilepsy-a syndrome of sensory-limbic hyperconnection. Cortex 1979, 15:357-384.
264. Bear D.M., Fedio P. Quantitative analysis of interictal behavior in temporal lobe epilepsy. Arch Neurol 1977, 34:454-467.
265. Devinsky O., Najjar S. Evidence against the existence of a temporal lobe epilepsy personality syndrome. Neurology 1999, 53(5 Suppl. 2):S13-S25.
266. Mungas D. Interictal behavior abnormality in temporal lobe epilepsy. A specific syndrome or nonspecific psychopathology?. Arch Gen Psychiatry 1982, 39:108-111.
267. Blumer D. Personality in epilepsy. Semin Neurol 1991, 11:155-166.
268. Rao S.M., Devinsky O., Grafman J., Stein M., Usman M., Uhde T.W., et al. Viscosity and social cohesion in temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 1992, 55:149-152.
269. Sachdev H.S., Waxman S.G. Frequency of hypergraphia in temporal lobe epilepsy: an index of interictal behaviour syndrome. J Neurol Neurosurg Psychiatry 1981, 44:358-360.
270. Hermann B.P., Whitman S., Arntson P. Hypergraphia in epilepsy: is there a specificity to temporal lobe epilepsy?. J Neurol Neurosurg Psychiatry 1983, 46:848-853.
271. Hermann B.P., Whitman S., Wyler A.R., Richey E.T., Dell J. The neurological, psychosocial and demographic correlates of hypergraphia in patients with epilepsy. J Neurol Neurosurg Psychiatry 1988, 51:203-208.
272. Hoeppner J.B., Garron D.C., Wilson R.S., Koch-Weser M.P. Epilepsy and verbosity. Epilepsia 1987, 28:35-40.
273. Kanner A.M., Soto A., Gross-Kanner H. Prevalence and clinical characteristics of postictal psychiatric symptoms in partial epilepsy. Neurology 2004, 62:708-713.
274. Kanner A.M., Morris H.H., Stagno S., Chelune G., Luders H. Remission of an obsessive-compulsive disorder following a right temporal lobectomy. Neuropsychiatry Neuropsychol Behav Neurol 1993, 6:126-129.
275. Barbieri V., Lo Russo G., Francione S., Scarone S., Gambini O. Association of temporal lobe epilepsy and obsessive-compulsive disorder in a patient successfully treated with right temporal lobectomy. Epilepsy Behav 2005, 6:617-619.
276. Kulaksizoglu I.B., Bebek N., Baykan B., Imer M., Gürses C., Spencer S., et al. Obsessive-compulsive disorder after epilepsy surgery. Epilepsy Behav 2004, 5:113-118.
277. Roth R.M., Jobst B.C., Thadani V.M., Gilbert K.L., Roberts D.W. New-onset obsessive-compulsive disorder following neurosurgery for medication-refractory seizure disorder. Epilepsy Behav 2009, 14:677-680.
278. Berlim M.T., Neufeld N.H., Van den Eynde F. Repetitive transcranial magnetic stimulation (rTMS) for obsessive-compulsive disorder (OCD): an exploratory meta-analysis of randomized and sham-controlled trials. J Psychiatr Res 2013, 47:999-1006.
279. Ettinger A.B., Reed M.L., Goldberg J.F., Hirschfeld R.M. Prevalence of bipolar symptoms in epilepsy vs other chronic health disorders. Neurology 2005, 65:535-540.
280. Ottman R., Lipton R.B., Ettinger A.B., Cramer J.A., Reed M.L., Morrison A., et al. Comorbidities of epilepsy: results from the Epilepsy Comorbidities and Health (EPIC) survey. Epilepsia 2011, 52:308-315.
281. Breslau N., Davis G.C., Andreski P. Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res 1991, 37:11-23.
282. Hesdorffer D.C., Ishihara L., Mynepalli L., Webb D.J., Weil J., Hauser W.A. Epilepsy, suicidality, and psychiatric disorders: a bidirectional association. Ann Neurol 2012, 72:184-191.
283. Adelow C., Andersson T., Ahlbom A., Tomson T. Hospitalization for psychiatric disorders before and after onset of unprovoked seizures/epilepsy. Neurology 2012, 78:396-401.
284. Hollander E., Schiffman E., Cohen B., Rivera-Stein M.A., Rosen W., Gorman J.M., et al. Signs of central nervous system dysfunction in obsessive-compulsive disorder. Arch Gen Psychiatry 1990, 47:27-32.
285. Ertekin B.A., Kulaksizoğlu I.B., Ertekin E., Gürses C., Bebek N., Gökyiğit A., et al. A comparative study of obsessive-compulsive disorder and other psychiatric comorbidities in patients with temporal lobe epilepsy and idiopathic generalized epilepsy. Epilepsy Behav 2009, 14:634-639.
286. Alegret M., Junque C., Valldeoriola F., Vendrell P., Martí M.J., Tolosa E. Obsessive-compulsive symptoms in Parkinson's disease. J Neurol Neurosurg Psychiatry 2001, 70:394-396.